059210 — Metabiomed Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Metabiomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	9,662	3,600	9,815	22,325	10,772
Depreciation
Amortisation
Non-Cash Items	-3,389	1,334	-636	-2,620	10,766
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,320	394	-3,156	-1,990	-7,113
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	11,136	9,159	10,217	22,633	19,833
Capital Expenditures	-2,100	-15,405	-11,494	-11,102	-20,461
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	8,424	827	-207	-32,261	13,892
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	6,324	-14,578	-11,701	-43,363	-6,569
Financing Cash Flow Items	1,949	—	—	20	-2,115
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-14,158	8,734	-1,023	23,410	-9,764
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,474	3,113	-2,430	3,721	3,439